11-65976832-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_005146.5(SART1):​c.1857+66C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00704 in 1,381,676 control chromosomes in the GnomAD database, including 562 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.014 ( 79 hom., cov: 33)
Exomes 𝑓: 0.0061 ( 483 hom. )

Consequence

SART1
NM_005146.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.223

Publications

2 publications found
Variant links:
Genes affected
SART1 (HGNC:10538): (spliceosome associated factor 1, recruiter of U4/U6.U5 tri-snRNP) This gene encodes two proteins, the SART1(800) protein expressed in the nucleus of the majority of proliferating cells, and the SART1(259) protein expressed in the cytosol of epithelial cancers. The SART1(259) protein is translated by the mechanism of -1 frameshifting during posttranscriptional regulation; its full-length sequence is not published yet. The two encoded proteins are thought to be involved in the regulation of proliferation. Both proteins have tumor-rejection antigens. The SART1(259) protein possesses tumor epitopes capable of inducing HLA-A2402-restricted cytotoxic T lymphocytes in cancer patients. This SART1(259) antigen may be useful in specific immunotherapy for cancer patients and may serve as a paradigmatic tool for the diagnosis and treatment of patients with atopy. The SART1(259) protein is found to be essential for the recruitment of the tri-snRNP to the pre-spliceosome in the spliceosome assembly pathway. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.146 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SART1NM_005146.5 linkc.1857+66C>T intron_variant Intron 14 of 19 ENST00000312397.10 NP_005137.1 O43290-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SART1ENST00000312397.10 linkc.1857+66C>T intron_variant Intron 14 of 19 1 NM_005146.5 ENSP00000310448.5 O43290-1
SART1ENST00000533386.1 linkn.18+66C>T intron_variant Intron 1 of 3 2

Frequencies

GnomAD3 genomes
AF:
0.0143
AC:
2174
AN:
152150
Hom.:
78
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0250
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0166
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.155
Gnomad SAS
AF:
0.00766
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000265
Gnomad OTH
AF:
0.0124
GnomAD4 exome
AF:
0.00613
AC:
7542
AN:
1229408
Hom.:
483
Cov.:
17
AF XY:
0.00595
AC XY:
3646
AN XY:
612606
show subpopulations
African (AFR)
AF:
0.0269
AC:
769
AN:
28626
American (AMR)
AF:
0.0112
AC:
394
AN:
35096
Ashkenazi Jewish (ASJ)
AF:
0.00195
AC:
44
AN:
22548
East Asian (EAS)
AF:
0.153
AC:
5396
AN:
35312
South Asian (SAS)
AF:
0.00400
AC:
296
AN:
73974
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
47740
Middle Eastern (MID)
AF:
0.00174
AC:
7
AN:
4032
European-Non Finnish (NFE)
AF:
0.000103
AC:
96
AN:
929954
Other (OTH)
AF:
0.0104
AC:
540
AN:
52126
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
402
805
1207
1610
2012
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
110
220
330
440
550
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0143
AC:
2185
AN:
152268
Hom.:
79
Cov.:
33
AF XY:
0.0159
AC XY:
1185
AN XY:
74448
show subpopulations
African (AFR)
AF:
0.0251
AC:
1043
AN:
41546
American (AMR)
AF:
0.0165
AC:
252
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3470
East Asian (EAS)
AF:
0.155
AC:
802
AN:
5170
South Asian (SAS)
AF:
0.00808
AC:
39
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000265
AC:
18
AN:
68016
Other (OTH)
AF:
0.0123
AC:
26
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
105
209
314
418
523
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00386
Hom.:
7
Bravo
AF:
0.0168
Asia WGS
AF:
0.0520
AC:
180
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
6.3
DANN
Benign
0.68
PhyloP100
0.22
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2276015; hg19: chr11-65744303; COSMIC: COSV56714024; COSMIC: COSV56714024; API